Jose Mcfaline Figueroa has Neurology as his primary medical specialty. Their primary office is: 450 Brookline Ave in Boston, Massachusetts.
They're a part of the: Dana-farber Cancer Institute, Inc. medical group which has around 542 members. You can call their office at - to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Columbia University College Of Physicians And Surgeons and graduated in 2013 (around 11 years of experience). They are listed as doing telehealth appointments.
Jose Mcfaline Figueroa
Dana-farber Cancer Institute, Inc.
450 Brookline Ave
Boston, Massachusetts 02215
-
Enter a starting address:
Medical School: Columbia University College Of Physicians And Surgeons
Graduation Year: 2013
The Primary Medical Specialty for Jose Mcfaline Figueroa is listed as: Neurology
Approximate Years of Experience: 11
PAC (PECOS ID)#: 5092942169
NPI #: 1558708784
NPI Created On: 05/29/2013
NPI Last Updated Listed as: 11/27/2018
Primary Taxonomy Code: 2084N0400X
License Number:
270422
Listed Gender: Male
Services and Procedures include:
55 Fruit St
Boston, MA
Massachusetts General Physicians Organization Inc
55 Fruit St
Boston, MA
The General Hospital Corporation
55 Fruit St
Boston, MA
Massachusetts General Physicians Organization Inc
75 Francis St
Boston, MA
Brigham And Women's Physicians Organization Inc
55 Fruit St
Boston, MA
The General Hospital Corporation
55 Fruit St
Boston, MA
The General Hospital Corporation
20 Prospect St
Milford Ma 01757-3042
Dana-farber Cancer Institute, Inc.
Medical Oncology
450 Brookline Ave
Boston Ma 02215-5418
Dana-farber Cancer Institute, Inc.
Medical Oncology
75 Francis St
Boston Ma 02115-6110
Dana-farber Cancer Institute, Inc.
Internal Medicine
450 Brookline Ave
Boston Ma 02215-5418
Dana-farber Cancer Institute, Inc.
Internal Medicine
22 Patriot Pl
Foxborough Ma 02035-1375
Dana-farber Cancer Institute, Inc.
Medical Oncology
75 Francis St
Boston Ma 02115-6110
Dana-farber Cancer Institute, Inc.
Medical Oncology
View all 542 members of Dana-farber Cancer Institute, Inc. medical group